n.激肽原

Kininogen is a precursor to bradykinin, a potent vasodilator and mediator of inflammation.
凝血酶原是激肽原的一种前体，后者是一种强大的血管舒张剂和炎症介质。
The activation of the kallikrein-kinin system leads to increased blood pressure in some individuals.
凯利克林-激肽原系统的激活会导致部分个体血压升高。
The level of kininogen in the blood can be a biomarker for certain inflammatory conditions.
血液中的激肽原水平可以作为某些炎症状况的生物标志物。
Researchers have found that certain medications can inhibit the breakdown of kininogen, reducing its effects on the body.
研究人员发现某些药物能抑制激肽原的分解，从而减少其对身体的影响。
Kininogen deficiency has been associated with an increased risk of cardiovascular diseases.
激肽原缺乏与心血管疾病的风险增加有关联。
The role of kininogen in the immune response is still an area of active research in medical science.
激肽原在免疫反应中的作用仍然是医学科学研究的热点领域。
During an allergic reaction, the release of kininogen from mast cells contributes to redness and swelling.
在过敏反应中，来自肥大细胞的激肽原释放会促进红肿现象。
The measurement of plasma kininogen levels can help diagnose and monitor hereditary angioedema.
测定血浆激肽原水平有助于诊断和监控遗传性血管水肿。
Kininogen plays a crucial role in the regulation of blood vessel permeability, particularly in the skin.
激肽原在调节血管通透性，特别是皮肤上起着关键作用。
Some researchers propose using kininogen as a therapeutic target in the treatment of chronic inflammatory disorders.
一些研究者提出将激肽原作为治疗慢性炎症疾病的治疗靶点。